Long-Term Botox: Muscle Atrophy, Safety and Decades of Data
Neuromodulators have been used in medicine for more than three decades. Here is what that track record tells us, and the long-term questions that remain open.
Microtox places tiny, diluted neuromodulator doses in the skin to reduce oil and refine pores. Dr. Arora explains this off-label option, its limits and risks.
If your forehead is shiny by lunchtime and your pores look larger every year, you have probably tried every mattifying product at the drugstore. Some patients ask me about a newer approach they have seen online, called Microtox, micro-Botox, or intradermal neuromodulator.
The concept is interesting and some early studies are encouraging. It is also off-label and less established than traditional wrinkle treatment. Here is a balanced look.
Standard treatment places a neuromodulator into muscle to reduce movement. Microtox uses a more diluted solution placed as many tiny, superficial injections into the skin itself, the dermis, rather than the muscle beneath.
In the skin, the product is thought to act on:
Small studies have reported reduced oiliness after intradermal botulinum toxin, including a 2013 study by Rose and Goldberg in patients with oily foreheads. Other reports describe improvements in pore appearance, fine texture, and facial flushing. However, these studies are generally small, short-term, and not all are placebo-controlled. There is no FDA approval for this use, and no standard protocol for dose or dilution.
In short: promising, plausible, and still early. I set expectations accordingly.
Near the forehead and mouth, careful dilution and depth matter, because product that reaches deeper muscles can affect expression. Treatment is performed by trained medical professionals under my oversight. Pricing depends on the area and dose; our pricing page has current rates, and we give you a specific quote at consultation.
For oily, textured skin, other treatments with longer track records include chemical peels, microneedling, and prescription skincare such as retinoids. Microtox can be one part of a plan rather than the whole plan.
No. Intradermal use of neuromodulators for oil and pores is off-label, and the evidence comes mainly from small studies.
It is designed to act on the skin rather than the muscles, so expression is usually preserved. Careful placement reduces the risk of unwanted muscle effects.
Many patients see effects for about three to four months, though results vary.
It is not a proven acne treatment. Reducing oil may help some people, but active acne needs its own plan.
Book a complimentary, no-commitment consultation. We will look at your skin closely and recommend the options with the best evidence for your concerns, including whether Microtox makes sense at all.
Ask about Easy Pay financing.
References: Rose AE, Goldberg DJ. Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatol Surg. 2013. · BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information. Allergan/AbbVie. · American Academy of Dermatology. Oily skin and large pores: dermatologists’ tips. aad.org.
This article is for general information only and is not medical advice. Treatments are provided only after consultation and evaluation by a licensed provider. Individual results vary.

Neuromodulators have been used in medicine for more than three decades. Here is what that track record tells us, and the long-term questions that remain open.
You cannot make Botox permanent, but you can avoid the habits that shortchange it. A practical guide to the first day, the first two weeks and the months after.
The same molecule that softens frown lines also treats migraine, bladder spasms and severe sweating. Here is a clear map of what is approved, what is off-label, and why it matters.